Insiders United Therapeutics Corporation

Equities

UTHR

US91307C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 09/07/2025 BST			5-day change	1st Jan Change
300.56 ^USD	+2.09%		+3.32%	-14.82%

06-30	United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says	MT
06-30	UBS Adjusts Price Target on United Therapeutics to $385 From $410, Maintains Buy Rating	MT

Insiders

United Therapeutics Insider Sold Shares Worth $3,079,514, According to a Recent SEC Filing	06-16	MT
United Therapeutics Insider Sold Shares Worth $3,121,543, According to a Recent SEC Filing	04-21	MT
United Therapeutics Insider Sold Shares Worth $1,138,200, According to a Recent SEC Filing	04-08	MT
United Therapeutics Insider Sold Shares Worth $3,367,984, According to a Recent SEC Filing	04-07	MT
United Therapeutics Insider Sold Shares Worth $796,991, According to a Recent SEC Filing	03-25	MT
United Therapeutics Insider Sold Shares Worth $3,566,800, According to a Recent SEC Filing	12-31	MT
United Therapeutics Insider Sold Shares Worth $3,701,377, According to a Recent SEC Filing	12-17	MT
United Therapeutics Insider Sold Shares Worth $3,676,877, According to a Recent SEC Filing	12-10	MT
United Therapeutics Insider Sold Shares Worth $2,828,672, According to a Recent SEC Filing	11-22	MT
United Therapeutics Insider Sold Shares Worth $2,855,916, According to a Recent SEC Filing	22/10/24	MT
United Therapeutics Insider Sold Shares Worth $2,821,050, According to a Recent SEC Filing	04/09/24	MT
United Therapeutics Insider Sold Shares Worth $2,318,397, According to a Recent SEC Filing	19/08/24	MT
United Therapeutics Insider Sold Shares Worth $2,409,782, According to a Recent SEC Filing	29/07/24	MT
United Therapeutics Insider Sold Shares Worth $2,355,544, According to a Recent SEC Filing	17/07/24	MT
United Therapeutics Insider Sold Shares Worth $2,395,035, According to a Recent SEC Filing	28/06/24	MT
United Therapeutics Insider Sold Shares Worth $2,285,941, According to a Recent SEC Filing	28/06/24	MT
United Therapeutics Corporation Announces Board Changes	27/06/24	CI
United Therapeutics Insider Sold Shares Worth $1,033,984, According to a Recent SEC Filing	17/06/24	MT
United Therapeutics Insider Sold Shares Worth $1,027,716, According to a Recent SEC Filing	14/06/24	MT
United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing	16/05/24	MT
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing	14/05/24	MT
United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing	10/05/24	MT
United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing	08/05/24	MT
United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing	07/05/24	MT
United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing	06/05/24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

United Therapeutics delivers 18th consecutive quarter of topline growth

June 17, 2025 at 11:16 am